“…This was similar to the findings in studies by Ayyamperumal et al and Hassan et al, where the male to female ratio was 1.8:1 and 1.3:1 respectively. 1,9 In our study, the most common malignancy (Table 3) was carcinoma of the breast, which was observed in 23.38% of the patients, followed by carcinoma of the cervix and leukemia, each in 9.17%, lymphomas, in 8.71%, carcinoma of lung in 5.50%, prostate in 4.58%, ovary and esophagus in 4.12% each, larynx in 3.66%, carcinoma tongue, endometrium, brain tumors in 3.21% each, carcinoma with unknown primary in 2.75%, carcinoma of bladder, penis, colon in 2.29% each, rectum in 1.83%, carcinoma of the stomach, thyroid, and renal cell carcinoma in 1.37% each, carcinoma of the , in 2.29% of the patients, pancreas, hepatocellular carcinoma in 0.91% each, and nasopharyngeal carcinoma in 0.45% of the patients. This is in contrast to findings by Wani et al, Hassan et al and Rajagopal et al which determined carcinoma of esophagus (19%), colorectal carcinoma (20%) and lymphomas (8%), respectively as the leading causes of malignancies.…”